Soliris injection is a medicine called a monoclonal antibody. Soliris is used to treat:
- patients-with a disease called Paroxysmal Nocturnal Hemoglobinuria (PNH).
- adults and children with a disease called atypical Hemolytic Uremic Syndrome (aHUS). Soliris is not for use in treating people with Shiga toxin E. coli related hemolytic uremic syndrome (STECHUS).
- adults with a disease called generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AchR) antibody positive
- adults with a disease called neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 (AQP4) antibody positive.
It is not known if Soliris is safe and effective in children with PNH, gMG, or NMOSD.
If you have an infusion-related reaction to soliris, your doctor may need to infuse soliris more slowly, or stop soliris